Business Context and Reporting Period
This Form 8-K Current Report is filed by The Boston Beer Company, Inc. (NYSE: SAM) on August 1, 2025. The report discloses a significant change in executive leadership, specifically the resignation of the President and Chief Executive Officer and the appointment of a successor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements and leadership transitions.
Material Changes
- CEO Resignation: Michael Spillane resigned as President and CEO, effective August 15, 2025. He cited personal reasons and confirmed no disagreements with the Company regarding operations or policies.
- Succession: C. James Koch, the Company's Founder and Chairman, will re-assume the role of President and CEO on August 16, 2025. Mr. Koch previously held this position from 1984 through January 2001.
- Board Status: Mr. Spillane will remain a non-independent member of the Board of Directors through his current term expiring at the 2026 Annual Meeting. His candidacy for re-election will be determined later.
Outlook, Management Commentary, and Compensation Details
The filing details a Transition Agreement approved by the Board and Compensation Committee on August 1, 2025, governing Mr. Spillane's departure:
- Transition Period: Mr. Spillane remains a salaried employee through November 15, 2025, and serves as a consultant/advisor from November 16, 2025, through March 31, 2026.
- Compensation:
- Salary through November 15, 2025: Annual rate of $905,000.
- Advisory Fee: $10,000 per quarter (pro-rated for Q4 2025).
- Bonus: 2025 bonus target set at 120% of salary; actual amount depends on Company results and will be determined in February 2026.
- Equity: Prior year grants continue to vest through March 2026; no new equity grants are eligible.
- Benefits: Full fringe benefits continue through November 15, 2025. The Company will reimburse the excess cost of COBRA health coverage premiums from November 15, 2025, until August 16, 2026, or until Mr. Spillane secures other employment.
- Successor Compensation: Mr. Koch's compensation as President and CEO will remain as previously reported with no adjustments for the role change.
Investor Verification Checklist
- Verify the effective dates of the leadership transition (August 15/16, 2025) and the duration of the advisory role (through March 31, 2026).
- Review the attached Exhibit 10.1 (Transition Agreement) for specific termination clauses and restrictive covenants.
- Monitor the Company's 2026 Annual Meeting proxy statement regarding Mr. Spillane's potential re-election to the Board.
- Confirm that Mr. Koch's re-assumption of the CEO role does not trigger any unexpected changes to existing executive compensation plans.